Squarepoint’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,901
Closed -$204K 4654
2025
Q4
$204K Buy
+59,901
New +$291K ﹤0.01% 3858
2025
Q2
Sell
-23,030
Closed -$125K 4800
2025
Q1
$125K Buy
+23,030
New +$131K ﹤0.01% 4156
2024
Q3
Sell
-154,390
Closed -$1.06M 4425
2024
Q2
$1.06M Buy
154,390
+29,692
+24% +$272K ﹤0.01% 2514
2024
Q1
$1.28M Buy
124,698
+70,248
+129% +$519K ﹤0.01% 2397
2023
Q4
$451K Sell
54,450
-1,439
-3% -$10.3K ﹤0.01% 3083
2023
Q3
$349K Buy
55,889
+39,866
+249% +$173K ﹤0.01% 3054
2023
Q2
$69.7K Sell
16,023
-610
-4% -$1.35K ﹤0.01% 3411
2023
Q1
$28.3K Buy
+16,633
New +$29.4K ﹤0.01% 3106
2021
Q4
Sell
-14,702
Closed -$91K 3365
2021
Q3
$91K Buy
+14,702
New +$125K ﹤0.01% 2688
2021
Q2
Sell
-24,372
Closed -$386K 3488
2021
Q1
$386K Buy
+24,372
New +$439K ﹤0.01% 2220

Other funds holding LFMD

Squarepoint's LFMD Position: Q1 2026 in Review

Squarepoint sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 59,901 shares — an estimated $204K sold.

Squarepoint first reported a position in LFMD in Q1 2021 and held it in 10 quarters. The position peaked at $1.28M in Q1 2024. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Squarepoint reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 59,901 LifeMD shares in Q1 2026, an estimated $204K.
  • Squarepoint first reported a position in LifeMD in Q1 2021 and held it in 10 quarters.
  • Squarepoint's LifeMD position peaked at $1.28M in Q1 2024.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.